Galmed Pharmaceuticals Ltd. (GLMD) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Galmed Pharmaceuticals Ltd. (GLMD) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $3.4M, listed on NASDAQ, employing roughly 3 people, carrying a beta of 0.62 to the broader market. Galmed Pharmaceuticals Ltd. Led by Allen Baharaff, public since 2014-03-13.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for GLMD as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →